13 9 2021 | 英語
Dr. Rumbelow will discuss the key role polysorbates play in stabilizing biopharmaceutical formulations and their excellent performance in preventing protein aggregation across a huge range of biopharmaceutical activities.
Croda, established in 1925 is known for some of our best selling and most studied excipients, polysorbates. Steve will cover the complex nature of polysorbates and how differences in purity levels in the various grades of commercially available polysorbate can impact performance. In addition, how the various grades and indeed specific components of polysorbates, can impact formulation stability, including changes in formulation stability and issues around protein self-aggregation.